An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

Based on an Apple study, researchers have developed a free asthma management tool, now available as an app, or on the web.

Lungpacer Medical today announced positive results from a Phase 1 clinical study evaluating its neurostimulation technology ...

That tracks with a 2018 study, which found that air purifiers improved the indoor air of patients with asthma. The Journal of ...

EXTON, PA — Lungpacer Medical has unveiled promising results from its groundbreaking STIMULUS trial, a Phase 1 study conducted in collaboration with Toronto General Hospital. Presented at the 2025 ...